Thomas Ciulla MD PC

[ad_1] RT @RetinalPhys: “If you’re interested in exploring possibilities in industry, there are a number of different ways to dip your toe in the… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Just published….Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases… https://t.co/f25J [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @RetinalPhys: Targeting RNA for Retinal Disease: RNA-based gene therapy is primed for a resurgence in retina. By Michael Gemayel, MD and… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Just co-authored: Retinal Physician – Targeting RNA for Retinal Disease https://t.co/u5tkg8AVOA [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Our research was featured this week in Modern Retina. “How DME patients may fare differently in ‘real world’ versus tr… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @RetinalPhys: Industry Opportunities for Retina Specialists: Personal perspectives from Drs. Ciulla, Rivers, and Chang on transitioning… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] @YoshiYonekawaMD @RetinalPhys Thanks Yoshi! When I finished training, I never thought I would witness so much innovation that has helped so many patients, have so many nice colleagues that are inspiration and gifted, & have so much intellectual freedom. It has been a fun …